Congress Materials

Medical Information
Saudi Arabia
 

This medical Information website is intended only for Healthcare Professionals in the Kingdom of Saudi Arabia. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

This content is intended for Healthcare professionals in Saudi Arabia. Would you like to proceed?

I am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
SelectI am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
I am not a healthcare professionalNo, go back to the patient portal
SelectI am not a healthcare professionalNo, go back to the patient portal
Non-Saudi Arabia residents click here.
The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Oral Presentation
Consolaro A, Lovell DJ, Synoverska O, Abud Mendoza C, Spindler A, Vyzhga Y, Alexeeva E, Chaitow J, Chiraseveenuprapund P, Shi H, Stockert L, Sawyerr G, Diehl A, Ruperto N, Brunner HI, for PRINTO/PRCSG September 21, 2021 PReS 2021 Juvenile Idiopathic Arthritis

Achievement of controlled disease and normal physical function in patients with polyarticular course juvenile idiopathic arthritis receiving tofacitinib: a post hoc analysis of data from a Phase 3, randomised, withdrawal trial

View Presentation
Oral Presentation
Ruperto N, Lovell DJ, Synoverska O, Abud Mendoza C, Spindler A, Vyzhga Y, Tirosh I, Imundo L, Alexeeva E, Chiraseveenuprapund P, Shi H, Sawyerr G, Blum A, Klaus P, Shapiro A, Diehl A, Ebrahim A, Martini A, Brunner HI for PRINTO/PRCSG September 21, 2021 PReS 2021 Juvenile Idiopathic Arthritis

Impact of concomitant methotrexate use and prior bDMARD exposure on tofacitinib efficacy and safety in patients with polyarticular course juvenile idiopathic arthritis: post hoc analysis of a Phase 3 withdrawal study

View Presentation